According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.15. In 2022 the company made an earnings per share (EPS) of -$11.29 a decrease over its 2021 EPS that were of $6.73.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$7.32 | -35.24% |
2022 | -$11.29 | -267.74% |
2021 | $6.73 | -194.33% |
2020 | -$7.14 | -576.58% |
2019 | $1.50 | -132.36% |
2018 | -$4.63 | 100.58% |
2017 | -$2.31 | 159.42% |
2016 | -$0.89 |